Tower Research Capital LLC (Trc) Enanta Pharmaceuticals Inc Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 7,202 shares of ENTA stock, worth $52,790. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,202
Previous 4,928
46.14%
Holding current value
$52,790
Previous $51,000
19.61%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding ENTA
# of Institutions
108Shares Held
19.7MCall Options Held
9.7KPut Options Held
12.4K-
Krensavage Asset Management, LLC New York, NY2.12MShares$15.5 Million7.2% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.11MShares$15.5 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$14.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$13.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.22MShares$8.95 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $152M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...